Global Metabolomics Market Size, Share, and COVID-19 Impact Analysis, By Product & Services (Metabolomics Instruments, Separation Tools, and Detection Tools), By Application (Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035.

Global Metabolomics Market Insights Forecasts To 2035

• The Global Metabolomics Market Size Was Estimated at USD 3.70 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 13.8% from 2025 to 2035
• The Worldwide Metabolomics Market Size is Expected to Reach USD 15.34 Billion by
• 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The global Metabolomics Market Size was worth around USD 3.70 Billion in 2024 and is Predicted to Grow to around USD 15.34 Billion by 2035 with a compound annual growth rate (CAGR) of 13.8 % from 2025 to 2035. The global metabolomics market is expanding due to rising R&D spending in the pharmaceutical and biopharmaceutical sectors, government and private funding opportunities for metabolomics research, and continuous advancements in metabolomics technology.  

Global Metabolomics Market Forecast and Revenue Outlook

• 2024 Market Size: USD 3.70 Billion
• 2035 Projected Market Size: USD 15.34 Billion
• CAGR (2025-2035): 13.8%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

The global economic area that arises from the characterization and study of small metabolite compounds produced by cellular metabolism in biological systems is known as the metabolomics market. The metabolomics market offers the ability to investigate biomarker discovery, drug testing, personalized medicine, toxicology, and nutrigenomics, as it characterizes metabolic phenotypes that can help to describe the cause of diseases and the functional response to treatment. The rapid, highly sensitive, and precise quantification methodologies like metabolomics are being positioned as required for analytical work with clinical specimens, as personalized medicine is being adopted. The investigation of metabolites in cells, tissues, and biofluids is the main focus of the metabolomics market, a developing area of life science. It is essential for figuring out biomarkers and comprehending biochemical processes.

The metabolomics market is expanding significantly due to the growing need for biomarker discovery and precision medicine. The increasing focus on precision medicine is a major factor propelling the metabolomics market. For instance, in November 2024, NIH created the Metabolomics Scientific Interest Group as a mechanism to increase awareness and collaboration between program staff and investigators. The group holds webinars and seminars to promote progress in metabolomics research.

Key Market Insights

• North America is expected to account for the largest share in the metabolomics market during the forecast period.
• In terms of product & services, the instruments segment is projected to lead the metabolomics market throughout the forecast period
• In terms of application, the biomarker discovery segment captured the largest portion of the market

Metabolomics Market Trends

• AI-Driven Data Analytics: Metabolite identification in precision medicine and drug research is being advanced by machine learning, which helps with metabolite identification.
• Multi-Omics Integration: Integration of metabolomics with genomics/proteomics is fast-tracking biomarkers for personalized treatment.
• High throughput technologies: High-end MS/NMR technology allows largely greater efficiency in research studies with the identification of over 1,000 metabolites.
• Liquid biopsy improvements: Improved sensitivity in non-invasive diagnostics is extending the use of liquid biopsy in chronic disease and cancer monitoring.

Report Coverage

This research report categorizes the metabolomics market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the metabolomics market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the metabolomics market.

Driving factors

The adoption of precision medicine movements is being supported by governments and financial organizations. The metabolomics market is expected to increase significantly as a result of this move toward customisation. The growing focus on precision medicine is the main factor driving the metabolomics market. Growing R&D funding in biotechnology and pharmaceuticals, the need for personalized medicine in the age of chronic illness, advancements in analytical tools like mass spectrometers, and substantial government-private investment in toxicology and biomarker discovery are the main factors propelling the metabolomics market.

Restraining Factor

The metabolomics market is restricted by factors such as the high expense of sophisticated analytical tools, the lack of uniformity in data analysis, the scarcity of qualified experts, and intricate regulatory frameworks for biomarker validation, all of which restrict scalability and adoption in clinical and research settings.

Market Segmentation 

The global metabolomics market is divided into product & services, and application.

Global Metabolomics Market, By Product & Service:

• The instruments segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.    

Based on product & service, the global metabolomics market is segmented into metabolomics instruments, separation tools, and detection tools. Among these, the instruments segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The instruments category consists of the fundamental tools needed for profiling and metabolite analysis.  The growth of the instrument segment is anticipated to be driven by factors like the technological advancements in analytical instruments, such as their miniaturization, automation, and computerization; the rise in research activities related to medicine, nutraceuticals, and metabolomics; and the improvement of healthcare infrastructure in developing countries for effective disease diagnosis and treatment.  

The detection tools segment in the metabolomics market is expected to grow at the fastest CAGR over the forecast period. The growing need for sophisticated analytical technologies, such as mass spectrometry and NMR, for precise metabolite identification and quantification is the main factor propelling the detection tools market.   

Global Metabolomics Market, By Application:

• The biomarker discovery segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.   

Based on application, the global metabolomics market is segmented into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine, and others. Among these, the biomarker discovery segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Metabolic biomarker discovery is increasingly being used to evaluate patients' pathophysiological health conditions. One of the main drivers of the segment's expansion has been the rise in the use of metabolic biomarkers to assess patients' pathophysiological health status. Metabolomics-driven biomarker discovery is especially useful for metabolic, cardiovascular, and cancer conditions.

The personalized medicine segment in the metabolomics market is expected to grow at the fastest CAGR over the forecast period. Metabolomics is being used more and more in personalized medicine, which provides treatment plans tailored to each individual. Thus, personalized medicine is a revolutionary use of metabolomics. The prevalence of chronic diseases is on the rise, which further supports the growth of personalized medicine.  

Regional Segment Analysis of the Global Metabolomics Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America Metabolomics Market Trends

North America is expected to hold the largest share of the global metabolomics market over the forecast period.

The North America region hosts the leading pharmaceutical and biotechnology companies that are actively integrating metabolomics into their R&D. The collaboration between these sectors is important for promoting new ideas, innovation and commercialization and will foster more product development. With high stakeholder interest in personalized medicine, North America is expected to maintain its place as the current leader market position.

U.S. Metabolomics Market Trends

The U.S. metabolomics market leverages advanced mass spectrometry and nuclear magnetic resonance technologies for the identification of biomarkers, drug development, and personalized medicine. Recent developments such as NIH initiatives like the Multi-Omics Consortium, as well as increases in burden in chronic disease, are driving advancements in the U.S. metabolomics market division.

Canada Metabolomics Market Trends

The CIHR-funded programs and the increasing frequency of chronic diseases are driving the Canada metabolomics market's robust expansion by utilizing modern mass spectrometry and NMR technologies for biomarker identification, medication development, and personalized medicine.

Asia Pacific Metabolomics Market Trends

Asia Pacific is expected to grow at the fastest CAGR in the metabolomics market during the forecast period.

The growth of Asia-Pacific investment in healthcare and research infrastructure in the region. China, India, and Japan are quickly adopting metabolomics by investigating diseases and working towards agricultural innovation in metabolomics. The burden of chronic disease in the Asia Pacific region are demand for improved diagnostics and biomarker identification. The role of government investment in genomics and multi-omics gives rise to opportunities for metabolomics applications.

India Metabolomics Market Trends

The India metabolomics market promotes biomarker discovery and tailored therapy by utilizing sophisticated mass spectrometry and NMR. The market is being driven by the USD 500 million precision medicine funding from ICMR, rising rates of chronic diseases, and growing biotechnology R&D.

China Metabolomics Market Trends

The China metabolomics market propels biomarker discovery and personalized medication by utilizing NMR and sophisticated mass spectrometry. The market is expected to increase significantly because to government funding, the rise in chronic disease rates, and the expansion of biotech R&D.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global metabolomics market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players In The Metabolomics Market Include

• Evotec SE
• Metabolon, Inc.
• Waters Corporation
• Creative Proteomics
• Danaher Corporation
• Shimadzu Corporation
• Owlstone Medical Ltd.
• Agilent Technologies, Inc.
• NIHS Metabolomics Core
• Bio-Rad Laboratories, Inc.
• Biocrates Life Sciences AG
• Thermo Fisher Scientific Inc.
• Metabolomic Discoveries GmbH
• Human Metabolome Technologies, Inc.
• Others 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In April 2025, Metabolon, Inc. launched a groundbreaking microbiome research solution, integrating metagenomics sequencing, bioinformatics tools, and a new microbiome metabolite panel. This powerful toolkit enhances insights into microbial functions, advancing life science research, diagnostics, and precision medicine applications.

• In September 2024, the commercial-stage biotechnology company Trinity Biotech plc, which specializes in diabetes management and human diagnostics, including biosensors, announced that it has acquired Metabolomics Diagnostics, an Irish deep-tech business that specializes in partnerships in the creation of new biomarkers. answers to complicated illnesses.

• In June 2024, Nightingale Health Plc, a leader in biomarker testing and risk prediction, and 23andMe Holding Co., a prominent preventive health and therapeutics company, announced a collaboration to test Nightingale Health's clinically validated and reasonably priced blood metabolomics panel on a cohort of 23andMe members.

• In June 2022, Bitome, a prominent point-of-care metabolite firm, sold assets to Ginkgo Bioworks, a leading horizontal platform for cell programming, to speed up the creation of bioproducts. Bitome launched technology that optimizes bioprocess optimization, offers quick insights into cell activity, and continuously monitors cell culture conditions using machine learning.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the metabolomics market based on the following segments:

 Global Metabolomics Market, By Product & Services

• Metabolomics Instruments
• Separation Tools
• Detection Tools

Global Metabolomics Market, By Application

• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Personalized Medicine
• Others

Global Metabolomics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa